866-997-4948(US-Canada Toll Free)

Colorectal Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Q4 2010

Published By :

GlobalData

Published Date : Nov 2010

Category :

Cancer

No. of Pages : 357 Pages


GlobalData, the industry analysis specialist, has released its new report, Colorectal Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Q4 2010. The report is an essential source of information and analysis on the global colorectal cancer therapeutics market. The report provides comprehensive information on colorectal cancer, highlighting the treatment guidelines. 

It identifies and analyses the key trends shaping and driving the global colorectal cancer therapeutics market. It analyses the treatment usage patterns in the global colorectal cancer therapeutics market. The report also provides insights into the competitive landscape and the emerging players expected to significantly alter the positions of the existing market leaders. 

The report provides valuable insights into the pipeline products within the global colorectal cancer sector. It quantifies the unmet need in the global colorectal cancer therapeutics market as well as in the individual markets such as the US and the top five countries in Europe, highlighting the opportunity for future players. 

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

The scope of the report includes: 

  • An overview of colorectal cancer which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines.
  • Annualized global colorectal cancer therapeutics market revenue, annual cost of therapy and treatment usage patterns data from 2001 to 2009, forecast for 11 years to 2020. 
  • Geographies covered in this report include the United States (US), the United Kingdom (UK), Italy, Spain, Germany, France Japan and BRIC countries that include Brazil, Russia, India and China
  • Insightful review of the key industry drivers, restraints and challenges and predicted impact of key events. 
  • Competitor assessment including drug launch analysis and drug sales forecasts.
  • Product profiles covering efficiency, safety, clinical study details, annual cost, regulatory approvals, LCM activities, product positioning and drug sales forecast.
  • Analysis of unmet need in the market and target product profile including opportunity for target product. 
  • Technology trends analytic framework to assess strength of pipeline. 
  • Pipeline analysis data providing a split across different phases, mechanisms of action being developed and emerging trends. The key classes of mechanism of action include EGFR inhibitors, VEGF inhibitors, monoclonal antibodies, angiogenesis inhibitors and others.
  • An overview of the most promising drugs including clinical study details, efficacy, safety, collaboration agreements, marketing rights, and launch analysis and drug sales forcasts to 2020.
  • Analysis of the current and future market competition in the US Colorectal Cancer therapeutics market. Company profiles including business description, financial overview and SWOT analysis. Key future market players covered include Hoffmann-La Roche Ltd, Bristol-Myers Squibb, Eli Lilly, Sanofi-Aventis, Debiopharm Group and Merck KGaA.
  • Analysis of licensing agreements during 2004-2010 in the colorectal cancer therapeutics market. M&A analysis which includes M&A deals by size and geography.
  • Strategic assessment of the market through market impact analysis, future market scenario and company analysis.
  • Direct quotes from key opinion leaders (KOL) or physicians in the colorectal cancer therapeutics market in the US.

Reasons to buy

The report will enhance your decision making capability. It will allow you to:

  • Develop business strategies and perform superior market quantification analysis by 
  • Understanding the trends shaping and driving the global colorectal cancer therapeutics market. 
  • Understanding treatment preferences of physicians in disease state and across treatment flow.
  • Accessing market sizing, forecasts and quantified growth opportunities in the global colorectal cancer therapeutics market till 2020.
  • Quantifying patient population in the global colorectal cancer market to better design product pricing & launch plans.
  • Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape by
  • Performing benchmarking analysis and growth opportunities against currently marketed products
  • Identifying market entry points based on safety, efficacy, and pricing parameters. 
  • Assessing competitiveness of products in market by understanding the strength and weakness of current competition. 
  • Develop and design your in-licensing and out-licensing strategies by 
  • Taking a comprehensive look of at the disease pipeline and identifying most promising paradigm shifting products.
  • Assessing strength of pipeline bases on first in class, me-too, generic and lifecycle management of products.
  • Track drug sales in the global colorectal cancer therapeutics market from 2001 to 2020
  • Identify the emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. 
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investments and strategic partnerships.
  • Whats the next big thing in the global colorectal cancer therapeutics market landscape? Identify, understand and capitalize.
Table of content

1 Table of contents 3

1.1 List of Tables 8
1.2 List of Figures 10

2 Disease Overview 15
2.1 Overview 15
2.2 Epidemiology 17
2.3 Etiology 17
2.4 Symptoms 17
2.4.1 Colon Cancer 17
2.4.2 Rectal Cancer 18
2.5 Diagnosis 19
2.5.1 FOBT 19
2.5.2 Endoscopy 19
2.5.3 Optical Colonoscopy 19
2.5.4 Virtual Colonoscopy 20
2.5.5 Double Contrast Barium Enema (DCBE) 20
2.6 Pathology 20
2.6.1 Grading 20
2.7 Treatment 21
2.7.1 Colon Cancer Treatment by Stage 22
2.7.2 Rectal Cancer Treatment by Stage 24
2.7.3 Chemotherapy Options 26
2.8 Treatment Guidelines 28

3 Market Characterization 30
3.1 Global 30
3.1.1 Market Size 30
3.1.2 Drivers and Barriers 35
3.1.3 Forecasts 37
3.1.4 Drug Sales 43
3.2 The US 47
3.2.1 Market Size 47
3.2.2 Drivers and Barriers 52
3.2.3 Forecasts 54
3.2.4 Drug Sales 61
3.2.5 Pricing and Reimbursements 63
3.3 The UK 64
3.3.1 Market Size 64
3.3.2 As a result of these factors, the patient volume was valued at 27,895 in 2009. 67
3.3.3 Drivers and Barriers 69
3.3.4 Impact on the Market 71
3.3.5 Forecasts 72
3.3.6 78
3.3.7 Drug Sales 78
3.3.8 81
3.3.9 Pricing and Reimbursements 81
3.4 Germany 82
3.4.1 Market Size 82
3.4.2 Drivers and Barriers 88
3.4.3 Impact on the Market 90
3.4.4 Forecasts 91
3.4.5 Drug Sales 97
3.4.6 Pricing and Reimbursements 99
3.5 France 100
3.5.1 Market Size 100
3.5.2 Drivers and Barriers 106
3.5.3 Impact on the Market 108
3.5.4 Forecasts 109
3.5.5 Drug Sales 114
3.5.6 Pricing & Reimbursements 117
3.6 Italy 118
3.6.1 Market Size 118
3.6.2 Drivers and Barriers 124
3.6.3 Impact on the Market 126
3.6.4 127
3.6.5 Forecasts 127
3.6.6 Drug Sales 132
3.6.7 Pricing and Reimbursements 135
3.7 Spain 136
3.7.1 Market Size 136
3.7.2 Drivers and Barriers 143
3.7.3 Impact on the Market 145
3.7.4 Forecasts 146
3.7.5 Drug Sales 151
3.7.6 Pricing and Reimbursements 154
3.8 Japan 155
3.8.1 Market Size 155
3.8.2 Drivers and Barriers 160
3.8.3 Impact on the Market 162
3.8.4 Forecasts 163
3.8.5 Future Impact 168
3.8.6 168
3.8.7 Drug Sales 169
3.8.8 Pricing and Reimbursements 171
3.9 Brazil 172
3.9.1 Market Size 172
3.9.2 Drivers and Restraints 177
3.9.3 Impact on the Market 179
3.9.4 Forecasts 180
3.9.5 Future Impact 185
3.10 India 186
3.10.1 Market Size 186
3.10.2 Drivers and Restraints 191
3.10.3 Impact on the Market 192
3.10.4 Forecasts 193
3.10.5 Future Impact 198
3.11 China 199
3.11.1 Market Size 199
3.11.2 Drivers and Restraints 204
3.11.3 Impact on the Market 206
3.11.4 Forecasts 207
3.11.5 Future Impact 212
3.12 Russia 213
3.12.1 Market Size 213
3.12.2 Drivers and Restraints 218
3.12.3 Impact on the Market 219
3.12.4 Forecasts 220
3.12.5 Future Impact 225
3.13 Key Takeaway 226

4 Competitor Assessment 227
4.1 Strategic Competitor Assessment 227
4.1.1 Overview 227
4.1.2 Benchmarking 227
4.1.3 Current Competitor Assessment 230
4.2 Launch Analysis and Sales Forecasts 231
4.2.1 Market Share Analysis of Drugs 231
4.3 Product Profiles 232
4.3.1 Avastin (bevacizumab) 233
4.3.2 Erbitux (cetuximab) 237
4.3.3 Xeloda (capecitabine) 244
4.3.4 Vectibix (panitumumab) 248
4.3.5 Eloxatin (oxaliplatin) 255
4.3.6 Camptosar (irinotecan) 260
4.3.7 Fluorouracil (5-FU) 263
4.3.8 Leucovorin (folinic acid) 264
4.4 Key Takeaway 265

5 Pipeline Assessment 266
5.1 Overview 266
5.2 Pipeline Analysis by Phase of Development 267
5.3 Pipeline by Mechanism of Action 268
5.4 Strategic Pipeline Assessment 269
5.4.1 Technology Trends Analytical Framework 269
5.5 Trends in Colorectal Cancer Pipeline 271
5.5.1 Increase in the Number of Vaccines in R&D Targeted at Stage III Colorectal Cancer 271
5.5.2 Novel First-in-Class Molecules in Late-stage Clinical Development Strengthening the Pipeline 271
5.5.3 Failure of key Molecules in Phase II and Phase III Development 271
5.6 Partners in Development 271
5.6.1 Licensing Agreements by Phase of Development 271
5.6.2 Licensing Agreements by Geography 274
5.6.3 Licensing Agreements: Colorectal Cancer Screening / Diagnostic Technology 274
5.7 Most Promising Drugs Profiles 276
5.7.1 Aflibercept 276
5.7.2 Brivanib 279
5.7.3 OncoVAX 280
5.7.4 TroVax 282
5.7.5 KRX-0401 (Perifosine) 284
5.8 Colorectal Cancer Pipeline Preclinical Phase 286
5.9 Colorectal Cancer Pipeline Phase I 286
5.10 Colorectal Cancer Pipeline Phase II 288
5.11 Colorectal Cancer Pipeline Phase III 295
5.12 Key Takeaway 298

6 Unmet Need and Target Product Profile 299
6.1 Unmet Need 300
6.2 Opportunity for Target Product 301
6.3 Target Product Profile 303
6.3.1 Ideal Characteristics 303
6.3.2 Target Product Description 304
6.4 Key Takeaway 304

7 Strategic Assessment 305
7.1 Key Events Impacting the Future Market 305
7.2 Market Impact Analysis 305
7.3 Future Market Scenario 305
7.4 Company Analysis 308
7.4.1 Market Leadership 308
7.4.2 Future Players in the Market 308
7.5 Key Takeaway 308

8 Company Profiles 309
8.1 F. Hoffmann La Roche 309
8.1.1 Business Description 309
8.1.2 Financial Overview 309
8.1.3 SWOT Analysis 309
8.2 Bristol-Myers Squibb 311
8.2.1 Business Description 311
8.2.2 Financial Overview 312
8.2.3 SWOT Analysis 312
8.3 Sanofi-Aventis 313
8.3.1 Business Description 313
8.3.2 Financial Overview 313
8.3.3 SWOT Analysis 314
8.4 Debiopharm Group 315
8.4.1 Business Description 315
8.5 Merck KGaA 315
8.5.1 Business Description 315
8.5.2 Financial Overview 316
8.5.3 SWOT Analysis 316
8.6 Regeneron 317
8.6.1 Business Description 317
8.6.2 Financial Overview 318
8.6.3 SWOT Analysis 318
8.7 Vaccinogen BD 319
8.7.1 Overview 319
8.7.2 SWOT Analysis 319
8.8 Oxford BioMedica 320
8.8.1 Business Description 320
8.8.2 Financial Overview 322
8.8.3 SWOT Analysis 322
8.9 Auron Healthcare GmbH 323
8.9.1 Company Overview 323
8.10 AEterna Zentaris 323
8.10.1 Business Description 323
8.10.2 Financial Overview 324
8.10.3 SWOT Analysis 324
8.11 Keryx 326
8.11.1 Business Description 326
8.11.2 Financial Overview 327
8.11.3 SWOT Anlaysis 327
8.12 Abbott Laboratories 330
8.12.1 Business Description 330
8.12.2 Financial Performance 330
8.12.3 SWOT Analysis 331
8.13 Pfizer 333
8.13.1 Business Description 333
8.13.2 Financial Overview 334
8.13.3 SWOT Analysis 334
8.14 Light Sciences Oncology, Inc 335
8.14.1 Business Description 335
8.14.2 Financial Overview 335
8.14.3 SWOT Analysis 335

9 Deals Analysis 338
9.1 Key Highlights 338
9.2 Key Deals Analysis 339
9.2.1 Eli Lilly Acquires ImClone 339
9.2.2 Astellas Pharma Acquires OSI Pharmaceuticals 339
9.2.3 Takeda Acquires IDM Pharma 339
9.2.4 Alchemia Acquires Meditech 339
9.2.5 Sanofi-Aventis Acquired Additional 15% Stake in Regeneron 339
9.2.6 BBM Holdings to Acquire YM Biosciences 339
9.2.7 Pfizer Acquires Assets of Campto from Sanofi-Aventis 340
9.2.8 Peptech Acquires cancer Antibodies from Scancell 340
9.2.9 Quest Pharma Tech Inc. Acquired Late Stage Immunotherapy Product Pipeline of Paladin Labs 340
9.2.10 Spectrum Pharmaceuticals Inc Acquired Oncology Drug Assets from Targent Inc 340
9.3 Deals Analysis by Geography 341
9.4 Deals Analysis by Deal Size 342

10 Expert Opinion 343
10.1 US 343
10.2 UK 344
10.3 Germany 345
10.4 Italy 346
10.5 Spain 347
10.6 Japan 348

11 Appendix 349
11.1 Market Definitions 349
11.2 Abbreviations 349
11.3 Research Methodology 351
11.3.1 Coverage 351
11.3.2 Secondary Research 351
11.3.3 Forecasting 352
11.3.4 Primary Research 355
11.3.5 Expert Panel validation 355
11.3.6 Contact Us 355
11.3.7 Disclaimer 355
11.3.8 Sources 355

List of Table


Table 1: Colorectal Cancer Therapeutics Market, Global, Staging of Colorectal Cancer, 2010 16
Table 2: Colorectal Cancer Therapeutics Market, Global, WHO Classification of Colorectal Carcinomas, 2010 21
Table 3: Colorectal Cancer Therapeutics Market, Global, Sales Value ($bn), 20012009 30
Table 4: Colorectal Cancer Therapeutics Market, Global, Annual Cost of Therapy ($), 20012009 31
Table 5: Colorectal Cancer Therapeutics Market, Global, Patient Volume (000), 20012009 32
Table 6: Colorectal Cancer Therapeutics Market, Global, Treatment Usage Patterns, 20012009 33
Table 7: Colorectal Cancer Therapeutics Market, Global, Sales Value ($bn), 20092020 37
Table 8: Colorectal Cancer Therapeutics Market, Global, Annual Cost of Therapy ($), 20092020 38
Table 9: Colorectal Cancer Therapeutics Market, Global, Patient Volume (000), 20092020 39
Table 10: Colorectal Cancer Therapeutics Market, Global, Treatment Usage Patterns (millions), 20092020 40
Table 11: Colorectal Cancer Therapeutics Market, Global, Drug Sales ($m), 2001-2010 44
Table 12: Colorectal Cancer Therapeutics Market, Global, Drug Sales ($m), 2010-2020 44
Table 13: Colorectal Cancer Therapeutics Market, The US, Sales Value ($bn), 20012009 47
Table 14: Colorectal Cancer Therapeutics Market, The US, Annual Cost of Therapy ($), 20012009 48
Table 15: Colorectal Cancer Therapeutics Market, The US, Patient Volume (1000s), 20012009 49
Table 16: Colorectal Cancer Therapeutics Market, The US, Treatment Usage Patterns, 20012009 50
Table 17: Colorectal Cancer Therapeutics Market, The US, Sales Value ($bn), 20092020 54
Table 18: Colorectal Cancer Therapeutics Market, The US, Sales Value ($bn), 20092020 55
Table 19: Colorectal Cancer Therapeutics Market, The US, Patient Volume (000), 20092020 56
Table 20: Colorectal Cancer Therapeutics Market, The US, Treatment Usage Patterns (millions), 20092020 57
Table 21: Colorectal Cancer, The US, Drug Sales ($m), 2001-2010 62
Table 22: Colorectal Cancer, The US, Drug Sales ($m), 2011-2020 62
Table 23: Colorectal Cancer Therapeutics Market, The UK, Sales Value ($bn), 20012009 64
Table 24: Colorectal Cancer Therapeutics Market, The UK, Annual Cost of Therapy ($), 20012009 65
Table 25: Colorectal Cancer Therapeutics Market, The UK, Patient Volume (000), 20012009 66
Table 26: Colorectal Cancer Therapeutics Market, The UK, Treatment Usage Patterns, 20012009 67
Table 27: Colorectal Cancer, The UK, Sales Value ($bn), 20092020 72
Table 28: Colorectal Cancer Therapeutics Market, The UK, Annual Cost of Therapy ($), 20092020 73
Table 29: Colorectal Cancer Therapeutics Market, The UK, Patient Volume, 20092020 74
Table 30: Colorectal Cancer Therapeutics Market, The UK, Treatment Usage Patterns (000), 20092020 75
Table 31: Colorectal Cancer Therapeutics Market, The UK, Drug Sales ($m), 2001-2020 80
Table 32: Colorectal Cancer Therapeutics Market, The UK, Drug Sales ($m), 2001-2020 80
Table 33: Colorectal Cancer Therapeutics Market, Germany, Sales Value ($bn), 20012009 82
Table 34: Colorectal Cancer Therapeutics Market, Germany, Annual Cost of Therapy ($), 20012009 83
Table 35: Colorectal Cancer Therapeutics Market, Germany, Patient Volume (000), 20012009 85
Table 36: Colorectal Cancer Therapeutics Market, Germany, Treatment Usage Patterns, 20012009 86
Table 37: Colorectal Cancer Therapeutics Market, Germany, Sales Value ($bn), 20092020 91
Table 38: Colorectal Cancer Therapeutics Market, Germany, Annual Cost of Therapy ($), 20092020 92
Table 39: Colorectal Cancer Therapeutics Market, Germany, Patient Volume (000), 20092020 93
Table 40: Colorectal Cancer Therapeutics Market, Germany, Treatment Usage Patterns, 20092020 94
Table 41: Colorectal Cancer Therapeutics Market, Germany, Drug Sales ($m), 2001-2010 98
Table 42: Colorectal Cancer Therapeutics Market, Germany, Drug Sales ($m), 2011-2020 98
Table 43: Colorectal Cancer Therapeutics Market, France, Sales Value ($), 20012009 100
Table 44: Colorectal Cancer Therapeutics Market, France, Annual Cost of Therapy ($), 20012009 101
Table 45: Colorectal Cancer Therapeutics Market, France, Patient Volume (000), 20012009 102
Table 46: Colorectal Cancer Therapeutics Market, France, Treatment Usage Patterns, 20012009 104
Table 47: Colorectal Cancer Therapeutics Market, France, Sales Value ($bn), 20092020 109
Table 48: Colorectal Cancer Therapeutics Market, France, Annual Cost of Therapy ($), 20092020 110
Table 49: Colorectal Cancer Therapeutics Market, France, Patient Volume (000), 20092020 111
Table 50: Colorectal Cancer Therapeutics Market, France, Treatment Usage Patterns, 20092020 112
Table 51: Colorectal Cancer Therapeutics Market, France, Drug Sales ($m), 2001-2010 116
Table 52: Colorectal Cancer Therapeutics Market, France, Drug Sales ($m), 2011-2020 116
Table 53: Colorectal Cancer Therapeutics Market, Italy, Sales Value ($bn), 20012009 118
Table 54: Colorectal Cancer Therapeutics Market, Italy, Annual Cost of Therapy ($), 20012009 119
Table 55: Colorectal Cancer Therapeutics Market, Italy, Patient Volume (000), 20012009 120
Table 56: Colorectal Cancer Therapeutics Market, Italy, Treatment Usage Patterns, 20012009 122
Table 57: Colorectal Cancer Therapeutics Market, Italy, Sales Value ($bn), 20092020 127
Table 58: Colorectal Cancer Therapeutics Market, Italy, Annual Cost of Therapy ($), 20092020 128
Table 59: Colorectal Cancer Therapeutics Market, Italy, Patient Volume, 20092020 129
Table 60: Colorectal Cancer Therapeutics Market, Italy, Treatment Usage Patterns, 20092020 130
Table 61: Colorectal Cancer Therapeutics Market, Italy, Drug Sales ($m), 2001-2010 134
Table 62: Colorectal Cancer Therapeutics Market, Italy, Drug Sales ($m), 2011-2020 134
Table 63: Colorectal Cancer Therapeutics Market, Spain, Sales Value ($bn), 20012009 136
Table 64: Colorectal Cancer Therapeutics Market, Spain, Annual Cost of Therapy ($), 20012009 137
Table 65: Colorectal Cancer Therapeutics Market, Spain, Patient Volume (1000s), 20012009 138
Table 66: Colorectal Cancer Therapeutics Market, Spain, Treatment Usage Patterns, 20012009 140
Table 67: Colorectal Cancer Therapeutics Market, Spain, Sales Value ($bn), 20092020 146
Table 68: Colorectal Cancer Therapeutics Market, Spain, Annual Cost of Therapy ($), 20092020 147
Table 69: Colorectal Cancer Therapeutics Market, Spain, Patient Volume (000), 20092020 148
Table 70: Colorectal Cancer Therapeutics Market, Spain, Treatment Usage Patterns, 20092020 149
Table 71: Colorectal Cancer Therapeutics Market, Spain, Drug Sales ($m), 2001-2010 153
Table 72: Colorectal Cancer Therapeutics Market, Spain, Drug Sales ($m), 2011-2020 153
Table 73: Colorectal Cancer Therapeutics Market, Japan, Sales Value ($bn), 20012009 155
Table 74: Colorectal Cancer Therapeutics Market, Japan, Annual Cost of Therapy ($), 20012009 156
Table 75: Colorectal Cancer Therapeutics Market, Japan, Patient Volume (000), 20012009 157
Table 76: Colorectal Cancer Therapeutics Market, Japan, Treatment Usage Patterns, 20012009 158
Table 77: Colorectal Cancer Therapeutics Market, Japan, Sales Value ($bn), 20092020 163
Table 78: Colorectal Cancer Therapeutics Market, Japan, Annual Cost of Therapy ($), 20092020 164
Table 79: Colorectal Cancer Therapeutics Market, Japan, Patient Volume (000), 20092020 165
Table 80: Colorectal Cancer Therapeutics Market, Japan, Treatment Usage Patterns, 20092020 166
Table 81: Colorectal Cancer Therapeutics Market, Japan, Drug Sales ($m), 2001-2020 170
Table 82: Colorectal Cancer Therapeutics Market, Japan, Drug Sales ($m), 2001-2020 170
Table 83: Colorectal Cancer Therapeutics Market, Brazil, Sales Value ($m), 20012009 172
Table 84: Colorectal Cancer Therapeutics Market, Brazil, Annual Cost of Therapy ($), 20012009 173
Table 85: Colorectal Cancer Therapeutics Market, Brazil, Patient Volume, 20012009 174
Table 86: Colorectal Cancer Therapeutics Market, Brazil, Treatment Usage Patterns, 20012009 175
Table 87: Colorectal Cancer Therapeutics Market, Brazil, Sales Value ($m), 20092020 180
Table 88: Colorectal Cancer Therapeutics Market, Brazil, Annual Cost of Therapy ($), 20092020 181
Table 89: Colorectal Cancer Therapeutics Market, Brazil, Patient Volume, 20092020 182
Table 90: Colorectal Cancer Therapeutics Market, Brazil, Treatment Usage Patterns, 20092020 183
Table 91: Colorectal Cancer Therapeutics Market, India, Sales Value ($m), 20012009 186
Table 92: Colorectal Cancer Therapeutics Market, India, Annual Cost of Therapy ($), 20012009 187
Table 93: Colorectal Cancer Therapeutics Market, India, Patient Volume, 20012009 188
Table 94: Colorectal Cancer Therapeutics Market, India, Treatment Usage Patterns, 20012009 189
Table 95: Colorectal Cancer Therapeutics Market, India, Sales Value ($m), 20092020 193
Table 96: Colorectal Cancer Therapeutics Market, India, Annual Cost of Therapy ($), 20092020 194
Table 97: Colorectal Cancer Therapeutics Market, India, Patient Volume, 20092020 195
Table 98: Colorectal Cancer Therapeutics Market, India, Treatment Usage Patterns, 20092020 196
Table 99: Colorectal Cancer Therapeutics Market, China, Sales Value ($m), 20012009 199
Table 100: Colorectal Cancer Therapeutics Market, China, Annual Cost of Therapy ($), 20012009 200
Table 101: Colorectal Cancer Therapeutics Market, China, Patient Volume, 20012009 201
Table 102: Colorectal Cancer Therapeutics Market, China, Treatment Usage Patterns, 20012009 202
Table 103: Colorectal Cancer Therapeutics Market, China, Sales Value ($m), 20092020 207
Table 104: Colorectal Cancer Therapeutics Market, China, Annual Cost of Therapy ($), 20092020 208
Table 105: Colorectal Cancer Therapeutics Market, China, Patient Volume, 20092020 209
Table 106: Colorectal Cancer Therapeutics Market, China, Treatment Usage Patterns, 20092020 210
Table 107: Colorectal Cancer Therapeutics Market, Russia, Sales Value ($m), 20012009 213
Table 108: Colorectal Cancer Therapeutics Market, Russia, Annual Cost of Therapy ($), 20012009 214
Table 109: Colorectal Cancer Therapeutics Market, Russia, Patient Volume, 20012009 215
Table 110: Colorectal Cancer Therapeutics Market, Russia, Treatment Usage Patterns, 20012009 216
Table 111: Colorectal Cancer Therapeutics Market, Russia, Sales Value ($m), 20092020 220
Table 112: Colorectal Cancer Therapeutics Market, Russia, Annual Cost of Therapy ($), 20092020 221
Table 113: Colorectal Cancer Therapeutics Market, Russia, Patient Volume, 20092020 222
Table 114: Colorectal Cancer Therapeutics Market, Russia, Treatment Usage Patterns, 20092020 223
Table 115: Colorectal Cancer, Global, Safety Profile of Standard Treatment, 2010 228
Table 116: Colorectal Cancer Therapeutics Market, Global, Benchmarking Major Marketed Products, 2010 232
Table 117: Colorectal Cancer, Global, Avastin Adverse Effects Incidence, 2010 234
Table 118: Colorectal Cancer Therapeutics Market, Global, Erbitux, Incidence of Adverse Effects, 2010 238
Table 119: Colorectal Cancer Therapeutics Market, Global, Xeloda, Adverse Effects Incidence, 2010 244
Table 120: Colorectal Cancer Therapeutics Market, Global, Vectibix, PRECEPT Interim Results, 2010 249
Table 121: Colorectal Cancer Therapeutics Market, Global, Vectibix, Incidence of Adverse Events, 2010 250
Table 122: Colorectal Cancer Therapeutics Market, Global, Eloxatin, Efficacy, 2010 255
Table 123: Colorectal Cancer Therapeutics Market, Global, Eloxatin, Incidence of Adverse Events, 2010 256
Table 124: Colorectal Cancer Therapeutics Market, Global, Technology Licensing Agreements Description, 2010 275
Table 125: Colorectal Cancer Therapeutics Market, Global, Preclinical Phase Pipeline, July 2010 286
Table 126: Colorectal Cancer, Global, Phase I Pipeline, July 2010 286
Table 127: Colorectal Cancer, Global, Phase II Pipeline, July 2010 288
Table 128: Colorectal Cancer, Global, Phase III Pipeline, July 2010 295
Table 129: Colorectal Cancer Therapeutics Market, Global, Commonly Prescribed Treatment Options, 2010 300
Table 130: Colorectal Cancer Therapeutics Market, Global, Characteristics of Ideal Drug Which Satisfies the Unmet Needs, 2010 303
Table 131: Colorectal Cancer Therapeutics Market, Global, Description of Ideal Drug Which Satisfies the Unmet Needs, 2010 304

List of Chart


Figure 1: Colorectal Cancer, Global, Colon Cancer Treatment Guidelines, 2010 28
Figure 2: Colorectal Cancer, Global, Rectal Cancer Treatment Guidelines, 2010 29
Figure 3: Colorectal Cancer Therapeutics Market, Global, Sales Value ($bn), 20012009 30
Figure 4: Colorectal Cancer Therapeutics Market, Global, Annual Cost of Therapy ($), 20012009 31
Figure 5: Colorectal Cancer Therapeutics Market, Global, Patient Volume, 20012009 32
Figure 6: Colorectal Cancer Therapeutics Market, Global, Treatment Usage Patterns, 20012009 33
Figure 7: Colorectal Cancer Therapeutics Market, Global, Market Drivers and Restraints, 2009 35
Figure 8: Colorectal Cancer Therapeutics Market, Global, The Impact of Historical Events on the Market, 2010 36
Figure 9: Colorectal Cancer Therapeutics Market, Global, Sales Value ($bn), 20092020 37
Figure 10: Colorectal Cancer Therapeutics Market, Global, Annual Cost of Therapy ($), 20092020 38
Figure 11: Colorectal Cancer Therapeutics Market, Global, Patient Volume (absolute), 20092020 39
Figure 12: Colorectal Cancer Therapeutics Market, Global, Treatment Usage Patterns, 20092020 40
Figure 13: Colorectal Cancer Therapeutics Market, Global, Future Market Drivers and Restraints, 20092020 42
Figure 14: Colorectal Cancer Therapeutics Market, Global, Drug Sales ($m), 2001-2020 43
Figure 15: Colorectal Cancer Therapeutics Market, Global, Market Breakdown by Drug Sales (%), 2009 46
Figure 16: Colorectal Cancer Therapeutics Market, The US, Sales Value ($bn), 20012009 47
Figure 17: Colorectal Cancer Therapeutics Market, The US, Annual Cost of Therapy ($), 20012009 48
Figure 18: Colorectal Cancer Therapeutics Market, The US, Patient Volume (absolute), 20012009 49
Figure 19: Colorectal Cancer Therapeutics Market, The US, Treatment Usage Patterns, 20012009 50
Figure 20: Colorectal Cancer Therapeutics Market, The US, Market Drivers and Restraints, 2009 52
Figure 21: Colorectal Cancer Therapeutics Market, The US, The Impact of Historical Events on the Market, 2010 53
Figure 22: Colorectal Cancer Therapeutics Market, The US, Sales Value ($bn), 20092020 54
Figure 23: Colorectal Cancer Therapeutics Market, The US, Annual Cost of Therapy ($), 20092020 55
Figure 24: Colorectal Cancer Therapeutics Market, The US, Patient Volume (absolute), 20092020 56
Figure 25: Colorectal Cancer Therapeutics Market, The US, Treatment Usage Patterns, 20092020 57
Figure 26: Colorectal Cancer Therapeutics Market, The US, Future Market Drivers and Restraints, 20092020 60
Figure 27: Colorectal Cancer, The US, Drug Sales ($m), 2001-2020 61
Figure 28: Colorectal Cancer Therapeutics Market, The UK, Sales Value ($bn), 20012009 64
Figure 29: Colorectal Cancer Therapeutics Market, The UK, Annual Cost of Therapy ($), 20012009 65
Figure 30: Colorectal Cancer Therapeutics Market, The UK, Patient Volume (absolute), 20012009 66
Figure 31: Colorectal Cancer Therapeutics Market, The UK, Treatment Usage Patterns, 20012009 67
Figure 32: Colorectal Cancer Therapeutics Market, The UK, Market Drivers and Restraints, 2009 69
Figure 33: Colorectal Cancer Therapeutics Market, The UK, The Impact of Historical Events on the Market, 2010 71
Figure 34: Colorectal Cancer Therapeutics Market, The UK, Sales Value ($bn), 20092020 72
Figure 35: Colorectal Cancer, The UK, Annual Cost of Therapy ($), 20092020 73
Figure 36: Colorectal Cancer Therapeutics Market, The UK, Patient Volume, 20092020 74
Figure 37: Colorectal Cancer Therapeutics Market, The UK, Treatment Usage Patterns, 20092020 75
Figure 38: Colorectal Cancer Therapeutics Market, The UK, Future Market Drivers and Restraints, 20092020 78
Figure 39: Colorectal Cancer Therapeutics Market, The UK, Drug Sales ($m), 2001-2020 79
Figure 40: Colorectal Cancer Therapeutics Market, Germany, Sales Value ($bn), 20012009 82
Figure 41: Colorectal Cancer Therapeutics Market, Germany, Annual Cost of Therapy ($), 20012009 83
Figure 42: Colorectal Cancer Therapeutics Market, Germany, Patient Volume, 20012009 85
Figure 43: Colorectal Cancer Therapeutics Market, Germany, Treatment Usage Patterns, 20012009 86
Figure 44: Colorectal Cancer Therapeutics Market, Germany, Market Drivers and Restraints, 2009 88
Figure 45: Colorectal Cancer Therapeutics Market, Germany, The Impact of Historical Events on the Market, 2010 90
Figure 46: Colorectal Cancer Therapeutics Market, Germany, Sales Value ($bn), 20092020 91
Figure 47: Colorectal Cancer Therapeutics Market, Germany, Annual Cost of Therapy ($), 20092020 92
Figure 48: Colorectal Cancer Therapeutics Market, Germany, Patient Volume, 20092020 93
Figure 49: Colorectal Cancer Therapeutics Market, Germany, Treatment Usage Patterns, 20092020 94
Figure 50: Colorectal Cancer Therapeutics Market, Germany, Future Market Drivers and Restraints, 20092020 96
Figure 51: Colorectal Cancer Therapeutics Market, Germany, Drug Sales ($m), 2001-2020 97
Figure 52: Colorectal Cancer Therapeutics Market, France, Sales Value ($bn), 20012009 100
Figure 53: Colorectal Cancer Therapeutics Market, France, Annual Cost of Therapy ($), 20012009 101
Figure 54: Colorectal Cancer Therapeutics Market, France, Patient Volume, 20012009 102
Figure 55: Colorectal Cancer Therapeutics Market, France, Treatment Usage Patterns, 20012009 103
Figure 56: Colorectal Cancer Therapeutics Market, France, Market Drivers and Restraints, 2009 106
Figure 57: Colorectal Cancer Therapeutics Market, France, The Impact of Historical Events on the Market, 2010 108
Figure 58: Colorectal Cancer Therapeutics Market, France, Sales Value ($bn), 20092020 109
Figure 59: Colorectal Cancer Therapeutics Market, France, Annual Cost of Therapy ($), 20092020 110
Figure 60: Colorectal Cancer Therapeutics Market, France, Patient Volume, 20092020 111
Figure 61: Colorectal Cancer Therapeutics Market, France, Treatment Usage Patterns, 20092020 112
Figure 62: Colorectal Cancer Therapeutics Market, France, Future Market Drivers and Restraints, 20092020 114
Figure 63: Colorectal Cancer Therapeutics Market, France, Drug Sales ($m), 2001-2020 115
Figure 64: Colorectal Cancer Therapeutics Market, Italy, Sales Value ($bn), 20012009 118
Figure 65: Colorectal Cancer Therapeutics Market, Italy, Annual Cost of Therapy ($), 20012009 119
Figure 66: Colorectal Cancer Therapeutics Market, Italy, Patient Volume, 20012009 120
Figure 67: Colorectal Cancer Therapeutics Market, Italy, Treatment Usage Patterns, 20012009 121
Figure 68: Colorectal Cancer Therapeutics Market, Italy, Market Drivers and Restraints, 2009 124
Figure 69: Colorectal Cancer Therapeutics Market, Italy, The Impact of Historical Events on the Market, 2010 126
Figure 70: Colorectal Cancer Therapeutics Market, Italy, Sales Value ($bn), 20092020 127
Figure 71: Colorectal Cancer Therapeutics Market, Italy, Annual Cost of Therapy ($), 20092020 128
Figure 72: Colorectal Cancer Therapeutics Market, Italy, Patient Volume, 20092020 129
Figure 73: Colorectal Cancer Therapeutics Market, Italy, Treatment Usage Patterns, 20092020 130
Figure 74: Colorectal Cancer Therapeutics Market, Italy, Future Market Drivers and Restraints, 20092020 132
Figure 75: Colorectal Cancer Therapeutics Market, Italy, Drug Sales ($m), 2001-2020 133
Figure 76: Colorectal Cancer Therapeutics Market, Spain, Sales Value ($bn), 20012009 136
Figure 77: Colorectal Cancer Therapeutics Market, Spain, Annual Cost of Therapy ($), 20012009 137
Figure 78: Colorectal Cancer Therapeutics Market, Spain, Patient Volume, 20012009 138
Figure 79: Colorectal Cancer Therapeutics Market, Spain, Treatment Usage Patterns, 20012009 140
Figure 80: Colorectal Cancer Therapeutics Market, Spain, Market Drivers and Restraints, 2009 143
Figure 81: Colorectal Cancer Therapeutics Market, Spain, The Impact of Historical Events on the Market, 2010 145
Figure 82: Colorectal Cancer Therapeutics Market, Spain, Sales Value ($bn), 20092020 146
Figure 83: Colorectal Cancer Therapeutics Market, Spain, Annual Cost of Therapy ($), 20092020 147
Figure 84: Colorectal Cancer Therapeutics Market, Spain, Patient Volume, 20092020 148
Figure 85: Colorectal Cancer Therapeutics Market, Spain, Treatment Usage Patterns, 20092020 149
Figure 86: Colorectal Cancer Therapeutics Market, Spain, Future Market Drivers and Restraints, 20092020 151
Figure 87: Colorectal Cancer Therapeutics Market, Spain, Drug Sales ($m), 2001-2020 152
Figure 88: Colorectal Cancer Therapeutics Market, Japan, Sales Value ($bn), 20012009 155
Figure 89: Colorectal Cancer Therapeutics Market, Japan, Annual Cost of Therapy ($), 20012009 156
Figure 90: Colorectal Cancer Therapeutics Market, Japan, Patient Volume, 20012009 157
Figure 91: Colorectal Cancer Therapeutics Market, Japan, Treatment Usage Patterns, 20012009 158
Figure 92: Colorectal Cancer Therapeutics Market, Japan, Market Drivers and Restraints, 2009 160
Figure 93: Colorectal Cancer Therapeutics Market, Japan, The Impact of Historical Events on the Market, 2010 162
Figure 94: Colorectal Cancer Therapeutics Market, Japan, Sales Value ($bn), 20092020 163
Figure 95: Colorectal Cancer Therapeutics Market, Japan, Annual Cost of Therapy ($), 20092020 164
Figure 96: Colorectal Cancer Therapeutics Market, Japan, Patient Volume, 20092020 165
Figure 97: Colorectal Cancer Therapeutics Market, Japan, Treatment Usage Patterns, 20092020 166
Figure 98: Colorectal Cancer Therapeutics Market, Japan, Future Events Expected to Impact the Market, 2010 168
Figure 99: Colorectal Cancer Therapeutics Market, Japan, Drug Sales ($m), 2001-2020 169
Figure 100: Colorectal Cancer Therapeutics Market, Brazil, Sales Value ($m), 20012009 172
Figure 101: Colorectal Cancer Therapeutics Market, Brazil, Annual Cost of Therapy ($), 20012009 173
Figure 102: Colorectal Cancer Therapeutics Market, Brazil, Patient Volume, 20012009 174
Figure 103: Colorectal Cancer Therapeutics Market, Brazil, Treatment Usage Patterns, 20012009 175
Figure 104: Colorectal Cancer Therapeutics Market, Brazil, Market Drivers and Restraints, 2009 177
Figure 105: Colorectal Cancer Therapeutics Market, Brazil, The Impact of Historical Events on the Market, 2010 179
Figure 106: Colorectal Cancer Therapeutics Market, Brazil, Sales Value ($m), 20092020 180
Figure 107: Colorectal Cancer Therapeutics Market, Brazil, Annual Cost of Therapy ($), 20092020 181
Figure 108: Colorectal Cancer Therapeutics Market, Brazil, Patient Volume, 20092020 182
Figure 109: Colorectal Cancer Therapeutics Market, Brazil, Treatment Usage Patterns, 20092020 183
Figure 110: Colorectal Cancer Therapeutics Market, Brazil, Future Market Drivers and Restraints, 20092020 185
Figure 111: Colorectal Cancer Therapeutics Market, India, Sales Value ($m), 20012009 186
Figure 112: Colorectal Cancer Therapeutics Market, India, Annual Cost of Therapy ($), 20012009 187
Figure 113: Colorectal Cancer Therapeutics Market, India, Patient Volume, 20012009 188
Figure 114: Colorectal Cancer Therapeutics Market, India, Treatment Usage Patterns, 20012009 189
Figure 115: Colorectal Cancer Therapeutics Market, India, Market Drivers and Restraints, 2009 191
Figure 116: Colorectal Cancer Therapeutics Market, India, The Impact of Historical Events on the Market, 2010 192
Figure 117: Colorectal Cancer Therapeutics Market, India, Sales Value ($m), 20092020 193
Figure 118: Colorectal Cancer Therapeutics Market, India, Annual Cost of Therapy ($), 20092020 194
Figure 119: Colorectal Cancer Therapeutics Market, India, Patient Volume, 20092020 195
Figure 120: Colorectal Cancer Therapeutics Market, India, Treatment Usage Patterns, 20092020 196
Figure 121: Colorectal Cancer Therapeutics Market, India, Future Market Drivers and Restraints, 20092020 198
Figure 122: Colorectal Cancer Therapeutics Market, China, Sales Value ($m), 20012009 199
Figure 123: Colorectal Cancer Therapeutics Market, China, Annual Cost of Therapy ($), 20012009 200
Figure 124: Colorectal Cancer Therapeutics Market, China, Patient Volume, 20012009 201
Figure 125: Colorectal Cancer Therapeutics Market, China, Treatment Usage Patterns, 20012009 202
Figure 126: Colorectal Cancer Therapeutics Market, China, Market Drivers and Restraints, 2010 204
Figure 127: Colorectal Cancer Therapeutics Market, China, The Impact of Historical Events on the Market, 2010 206
Figure 128: Colorectal Cancer Therapeutics Market, China, Sales Value ($m), 20092020 207
Figure 129: Colorectal Cancer Therapeutics Market, China, Annual Cost of Therapy ($), 20092020 208
Figure 130: Colorectal Cancer Therapeutics Market, China, Patient Volume, 20092020 209
Figure 131: Colorectal Cancer Therapeutics Market, China, Treatment Usage Patterns, 20092020 210
Figure 132: Colorectal Cancer Therapeutics Market, China, Future Market Drivers and Restraints, 20092020 212
Figure 133: Colorectal Cancer Therapeutics Market, Russia, Sales Value ($m), 20012009 213
Figure 134: Colorectal Cancer Therapeutics Market, Russia, Annual Cost of Therapy ($), 20012009 214
Figure 135: Colorectal Cancer Therapeutics Market, Russia, Patient Volume, 20012009 215
Figure 136: Colorectal Cancer Therapeutics Market, Russia, Treatment Usage Patterns, 20012009 216
Figure 137: Colorectal Cancer Therapeutics Market, Russia, Market Drivers and Restraints, 2009 218
Figure 138: Colorectal Cancer Therapeutics Market, Russia, The Impact of Historical Events on the Market, 2010 219
Figure 139: Colorectal Cancer Therapeutics Market, Russia, Sales Value ($m), 20092020 220
Figure 140: Colorectal Cancer Therapeutics Market, Russia, Annual Cost of Therapy ($), 20092020 221
Figure 141: Colorectal Cancer Therapeutics Market, Russia, Patient Volume, 20092020 222
Figure 142: Colorectal Cancer Therapeutics Market, Russia, Treatment Usage Patterns, 20092020 223
Figure 143: Colorectal Cancer Therapeutics Market, Russia, Future Market Drivers and Restraints, 20092020 225
Figure 144: Colorectal Cancer Therapeutics Market, Global, Clinical Endpoints for Benchmarking, 2010 228
Figure 145: Colorectal Cancer Therapeutics Market, Global, Strategic Competitor Assessment of Major Marketed Drugs, 2010 230
Figure 146: Colorectal Cancer Therapeutics Market, Global, Sales Forecast Split by Therapies, 2001-2020 231
Figure 147: Colorectal Cancer Therapeutics Market, Global, Avastin, Life Cycle Management Activities, 20042010 235
Figure 148: Colorectal Cancer Therapeutics Market, Global, Avastin, Sales Forecast ($m), 2004-2020 236
Figure 149: Colorectal Cancer Therapeutics Market, Global, Avastin, Market Share Analysis (%), 2009 237
Figure 150: Colorectal Cancer Therapeutics Market, Global, Erbitux, Life Cycle Management Activities, 20042010 241
Figure 151: Colorectal Cancer Therapeutics Market, Global, Erbitux, Sales Forecast ($m), 2004-2020 242
Figure 152: Colorectal Cancer Therapeutics Market, Global, Erbitux, Market Share Analysis (%), 2009 243
Figure 153: Colorectal Cancer Therapeutics Market, Global, Xeloda, Chemical Structure, 2010 244
Figure 154: Colorectal Cancer Therapeutics Market, Global, Xeloda, Life Cycle Management Activities, 2010 246
Figure 155: Colorectal Cancer Therapeutics Market, Global, Xeloda, Sales Forecast ($m), 2001-2020 247
Figure 156: Colorectal Cancer Therapeutics Market, Global, Xeloda, Market Share Analysis (%), 2009 248
Figure 157: Colorectal Cancer Therapeutics Market, Global, Vectibix, Life Cycle Management Activities, 2010 252
Figure 158: Colorectal Cancer Therapeutics Market, Global, Vectibix, Sales Forecast ($m), 2006-2020 253
Figure 159: Colorectal Cancer Therapeutics Market, Global, Vectibix, Market Share Analysis (%), 2006-2020 254
Figure 160: Colorectal Cancer Therapeutics Market, Global, Eloxatin, Chemical Structure, 2010 255
Figure 161: Colorectal Cancer Therapeutics Market, Global, Eloxatin, Life Cycle Management Activities, 2010 257
Figure 162: Colorectal Cancer Therapeutics Market, Global, Eloxatin, Sales Forecast ($m), 2001-2020 258
Figure 163: Colorectal Cancer Therapeutics Market, Global, Eloxatin, Market Share Analysis (%), 2009 259
Figure 164: Colorectal Cancer Therapeutics Market, Global, Camptosar, Chemical Structure 260
Figure 165: Colorectal Cancer Therapeutics Market, Global, Camptosar, Life Cycle Management Activities, 2010 261
Figure 166: Colorectal Cancer Therapeutics Market, Global, Camptosar, Sales Forecast ($m), 2001-2020 262
Figure 167: Colorectal Cancer Therapeutics Market, Global, Camptosar, Market Share Analysis (%), 2009 263
Figure 168: Colorectal Cancer Therapeutics Market, Global, Fluorouracil, Chemical Structure 263
Figure 169: Colorectal Cancer Therapeutics Market, Global, Leucovorin, Chemical Structure 264
Figure 170: Colorectal Cancer Therapeutics Market, Global, 5-FU/LV, Sales Forecast ($m), 2001-2020 265
Figure 171: Colorectal Cancer Therapeutics Market, Global, Clinical Trials by Therapy (%), 2010 266
Figure 172: Colorectal Cancer Therapeutics Market, Global, Clinical Trials by Phase of Development (%), 2010 267
Figure 173: Colorectal Cancer Therapeutics Market, Global, Pipeline by Mechanism of Action, 2010 268
Figure 174: Colorectal Cancer Therapeutics Market, Global, Technology Trends Analytic Framework of Pipeline Drugs, 2010 269
Figure 175: Colorectal Cancer Therapeutics Market, Global, Technology Trends Description of Pipeline Drugs, 2010 270
Figure 176: Colorectal Cancer Therapeutics Market, Global, Licensing Agreements by Phase of Development (%), 2004-2010 272
Figure 177: Colorectal Cancer Therapeutics Market, Global, Licensing Agreements by Geography (%), 2010 274
Figure 178: Colorectal Cancer Therapeutics Market, Global, Licensing Agreements by Screening/Diagnostic Technology (%), 2010 275
Figure 179: Colorectal Cancer Therapeutics Market, Global, Aflibercept Sales Forecast ($m), 2011-2020 278
Figure 180: Colorectal Cancer Therapeutics Market, Global, Brivanib Chemical Structure, 2010 279
Figure 181: Colorectal Cancer Therapeutics Market, Global, Brivanib Sales Forecasts ($m), 2013-2020 280
Figure 182: Colorectal Cancer Therapeutics Market, Global, OncoVAX Sales Forecast ($m), 2011-2020 282
Figure 183: Colorectal Cancer Therapeutics Market, Global, TroVax Sales Forecast ($m), 2014-2020 284
Figure 184: Colorectal Cancer Therapeutics Market, Global, Perifosine Chemical Structure, 2010 284
Figure 185: Colorectal Cancer Therapeutics Market, Global, Median Overall Survival for Metastatic Colorectal Cancer Patients (months), 2010 299
Figure 186: Colorectal Cancer Therapeutics Market, Global, Opportunity and Unmet Need, 2010 301
Figure 187: Colorectal Cancer Therapeutics Market, Unmet Need by Geography, 2010 302
Figure 188: Colorectal Cancer, Global, Key Events Impacting the Future Market 305
Figure 189: Colorectal Cancer Therapeutics Market, Global, Implications for Future Market Competition, 2010 307
Figure 190: Colorectal Cancer Therapeutics Market, Global, Merger and Acquisition Deals by Geography, 2010 338
Figure 191: Colorectal Cancer Therapeutics Market, Global, Merger and Acqusition Deals by Geography (%), 2010 341
Figure 192: Colorectal Cancer Therapeutics Market, Global, Merger and Acquisition Deals by Deal Size (%), 2010 342
Figure 193: Colorectal Cancer Therapeutics Market, The US, Key Data Inputs from Key Opinion Leader Interviews, July 2010 343
Figure 194: Colorectal Cancer Therapeutics Market, The UK, Key Data Inputs from Key Opinion Leader Interviews, July 2010 344
Figure 195: Colorectal Cancer Therapeutics Market, Germany, Key Data Inputs from Key Opinion Leader Interviews, July 2010 345
Figure 196: Colorectal Cancer Therapeutics Market, Italy, Key Data Inputs from Key Opinion Leader Interviews, July 2010 346
Figure 197: Colorectal Cancer Therapeutics Market, Spain, Key Data Inputs from Key Opinion Leader Interviews, July 2010 347
Figure 198: Colorectal Cancer Therapeutics Market, Japan, Key Data Inputs from Key Opinion Leader Interviews, July 2010 348
Figure 199: GlobalData Market Forecasting Model 354

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *